{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:34:31Z","timestamp":1787762071906,"version":"build-2784847793"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:p>Chronic kidney disease (CKD) and dementia are common morbidities of elders. Serum cystatin C has been suggested to be an ideal marker for kidney function. The current study aimed to detect the serum levels of cystatin C in CKD patients and to correlate these levels to cognitive performance. The study involved 90 subjects aged 65 years and more, divided into two groups: Group 1: 60 patients with CKD, and Group 2: 30 control participants. Exclusion criteria included cardiac failure, hepatic failure, thyroid diseases, dialysis for more than one month, polycystic kidney disease, organ transplantation, and immunosuppressive therapy within the past six months. All participants had routine laboratory workup, serum cystatin C using enzyme-linked immunosorbent assay kits, and cognitive assessment using mini-mental state examination (MMSE). Serum cystatin level was significantly high in CKD patients while MMSE scores were significantly lower in CKD patients. A high significant negative correlation was found between serum cystatin C levels and both degree of cognitive impairment and glomerular filtration rate (GFR). Also, a significant positive correlation was found between the degree of cognitive impairment and GFR levels. Serum cystatin levels are significantly associated with cognitive impairment in CKD patients, and this correlation becomes more evident with the worsening of CKD stages. That may help in better understanding of the pathogenesis of dementia in CKD patients with the emergence of therapeutic options depending on these data.<\/jats:p>","DOI":"10.4103\/1319-2442.379027","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T06:38:15Z","timestamp":1686983895000},"page":"288-295","source":"Crossref","is-referenced-by-count":2,"title":["Association of Serum Levels of Cystatin C and Cognition in a Cohort of Egyptian Elderly Patients with Chronic Kidney Disease"],"prefix":"10.4103","volume":"33","author":[{"given":"Marwa A.","family":"Saad","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Geriatric Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan N.","family":"Abo-Raya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geriatric Unit, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A.","family":"Waly","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shark El-Madinah Hospital, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neveen L.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"R1-20230720","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classi-fication, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R2-20230720","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R3-20230720","article-title":"Egypt | Institute for Health Metrics and Evaluation"},{"key":"R4-20230720","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0971-4065.111840","article-title":"Serum cystatin C as a marker of renal function in detection of early acute kidney injury","volume":"23","author":"Murty","year":"2013","journal-title":"Indian J Nephrol"},{"key":"R5-20230720","first-page":"203","article-title":"Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function","volume":"54","author":"Randers","year":"2000","journal-title":"Clin Nephrol"},{"key":"R6-20230720","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","article-title":"Cognitive impairment in the aging dialysis and chronic kidney disease populations: An occult burden","volume":"15","author":"Murray","year":"2008","journal-title":"Adv Chronic Kidney Dis"},{"key":"R7-20230720","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0b013e3181b72629","article-title":"Kidney function is associated with the rate of cognitive decline in the elderly","volume":"73","author":"Buchman","year":"2009","journal-title":"Neurology"},{"key":"R8-20230720","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/ndt\/gfp230","article-title":"Chronic kidney disease is associated with incident cognitive impairment in the elderly: The INVADE study","volume":"24","author":"Etgen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20230720","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","article-title":"Moderate renal impairment and risk of dementia among older adults: The cardio-vascular health cognition study","volume":"15","author":"Seliger","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R10-20230720","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2008.05.004","article-title":"Kidney function and cognitive impairment in US adults: The reasons for geographic and racial differences in stroke (REGARDS) study","volume":"52","author":"Kurella Tamura","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R11-20230720","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2003.11.006","article-title":"Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation","volume":"25","author":"Sastre","year":"2004","journal-title":"Neurobiol Aging"},{"key":"R12-20230720","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000100021","article-title":"Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease","volume":"23","author":"Chuo","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R13-20230720","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/jgs.12986","article-title":"Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: The chronic renal insufficiency cohort cognitive study","volume":"62","author":"Yaffe","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"R14-20230720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365519950185940","article-title":"Evaluation of the dade behring N latex cystatin c assay on the dade behring nephelometer II system","volume":"59","author":"Erlandsen","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"R15-20230720","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R16-20230720","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0447.2009.01461.x","article-title":"Cost-of-illness studies of dementia: A systematic review focusing on stage dependency of costs","volume":"121","author":"Quentin","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"R17-20230720","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R18-20230720","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/gerona\/gls173","article-title":"Epidemiology of chronic kidney disease among older adults: A focus on the oldest old","volume":"67","author":"Bowling","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R19-20230720","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/j.1532-5415.2012.04238.x","article-title":"Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults","volume":"60","author":"O'Hare","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"R20-20230720","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1681\/ASN.2012050536","article-title":"Cognitive disorders and dementia in CKD: The neglected kidney-brain axis","volume":"24","author":"Bugnicourt","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R21-20230720","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archinternmed.2007.40","article-title":"Cystatin C and aging success","volume":"168","author":"Sarnak","year":"2008","journal-title":"Arch Intern Med"},{"key":"R22-20230720","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-2010-1289","article-title":"The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease","volume":"19","author":"Maetzler","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R23-20230720","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1681\/ASN.2005010006","article-title":"Cystatin C and subclinical brain infarction","volume":"16","author":"Seliger","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R24-20230720","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archneur.57.11.1579","article-title":"Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease","volume":"57","author":"Finckh","year":"2000","journal-title":"Arch Neurol"},{"key":"R25-20230720","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ana.21383","article-title":"Cystatin C as a marker of cognitive function in elders: Findings from the health ABC study","volume":"63","author":"Yaffe","year":"2008","journal-title":"Ann Neurol"},{"key":"R26-20230720","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.ajkd.2004.08.044","article-title":"Chronic kidney disease and cognitive impairment in menopausal women","volume":"45","author":"Kurella","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R27-20230720","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-1331.2009.02809.x","article-title":"Cystatin C as an index of cerebral small vessel disease: Results of a cross-sectional study in community-based Japanese elderly","volume":"17","author":"Wada","year":"2010","journal-title":"Eur J Neurol"},{"key":"R28-20230720","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.neurobiolaging.2012.10.022","article-title":"Mapping creatinine-and cystatin C-related white matter brain deficits in the elderly","volume":"34","author":"Rajagopalan","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R29-20230720","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.0b013e318217e7c8","article-title":"Correlations between MRI white matter lesion location and executive function and episodic memory","volume":"76","author":"Smith","year":"2011","journal-title":"Neurology"},{"key":"R30-20230720","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/gerona\/glu189","article-title":"Cystatin C and cognitive impairment 10 years later in older women","volume":"70","author":"Slinin","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R31-20230720","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/01.wnl.0000326894.40353.93","article-title":"Serum cystatin C and the risk of Alzheimer disease in elderly men","volume":"71","author":"Sundel\u00f6f","year":"2008","journal-title":"Neurology"},{"key":"R32-20230720","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3233\/JAD-2010-101095","article-title":"Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment","volume":"22","author":"Ghidoni","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"R33-20230720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1034\/j.1600-0404.2000.101004279.x","article-title":"Serum and cerebrospinal fluid cystatin C levels in vascular and Alzheimer's dementia","volume":"101","author":"K\u00e1lm\u00e1n","year":"2000","journal-title":"Acta Neurol Scand"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.379027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:13:03Z","timestamp":1787760783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.379027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/1319-2442.379027","relation":{},"ISSN":["1319-2442","2320-3838"],"issn-type":[{"value":"1319-2442","type":"print"},{"value":"2320-3838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}